# Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous Leishmaniasis

> **NCT05708625** · PHASE3 · UNKNOWN · sponsor: **Zagazig University** · enrollment: 136 (estimated)

## Conditions studied

- Leishmaniasis, Cutaneous

## Interventions

- **DRUG:** Intralesional Sodium stibogluconate
- **PROCEDURE:** Intralesional Cryotherapy
- **DRUG:** Intralesional Voriconazole
- **DRUG:** Oral doxycycline

## Key facts

- **NCT ID:** NCT05708625
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2024-03-01
- **Target enrollment:** 136 (ESTIMATED)
- **Last updated:** 2023-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05708625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05708625, "Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous Leishmaniasis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05708625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*